科研之友
微信
新浪微博
Facebook
分享链接
摘要
Functional exploration of neuroendocrine tumor (NET) has the benefit of getting several radiopharmaceuticals. The main ones are MIBG, radiolabeled somatostatin analogues, 18F-DOPA, and 18FFDG. Their main indications are reminded in medullary thyroid cancer, pheochromocytoma, and paraganglioma and digestive endocrine tumors.
- 出版日期2013-10
